Physician profile
Jonathan Hwang
NPI 1548353592
$714.47
in general payments reported to CMS, 2019-2025
17 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.88 · 2020: $54.45 · 2021: $32.31 · 2022: $96.25 · 2023: $117 · 2024: $236 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $510.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $132.06 | 2023-2024 | Orgovyx |
| Janssen Biotech, INC. | $124.47 | 2024 | Erleada |
| Coloplast Corp | $57.28 | 2024 | |
| Merck Sharp & Dohme LLC | $56.34 | 2025 | Keytruda, Keytruda Qlex |
| Blue Earth Diagnostics | $51.41 | 2022-2023 | |
| Progenics Pharmaceuticals, INC. | $37.06 | 2022 | |
| Intuitive Surgical, INC. | $36.27 | 2020 | |
| Genzyme Corporation | $32.19 | 2022 | |
| Novartis Pharmaceuticals Corporation | $32.08 | 2025 | |
| Urogen Pharma, INC. | $24.95 | 2025 | |
| Immunitybio, INC. | $24.55 | 2025 | |
| 180 Medical, INC. | $20.88 | 2019 | |
| Ferring Pharmaceuticals INC. | $20.05 | 2025 | Adstiladrin |
| Davol INC. | $18.18 | 2020 | |
| Urovant Sciences INC | $16.36 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $15.95 | 2021 | |
| Cook Medical LLC | $14.39 | 2024 | Cook |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Hwang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.